Cancer treatment: New research finds ‘less’ is more effective for patients, produce fewer side-effects

Research suggests that reducing cancer treatments may enhance patient comfort without compromising recovery. Studies are questioning the need for traditional approaches and exploring the benefits of less invasive procedures for improved outcomes.

Sounak Mukhopadhyay
Published3 Jun 2024, 12:33 PM IST
Researchers are now re-evaluating traditional cancer treatments, questioning the necessity of longstanding approaches.
Researchers are now re-evaluating traditional cancer treatments, questioning the necessity of longstanding approaches.(Pexels)

There was a time when more was better for cancer patients, but not anymore. Doctors have reported that reducing cancer treatments can improve patient comfort without affecting their recovery. This approach is a shift from 30 years ago when cancer treatment focused on increasing the amount of care, the New York Post reported.

Also Read: Lung cancer was a death sentence. Now drugs are saving lives

Researchers are now re-evaluating traditional cancer treatments, questioning the necessity of longstanding approaches. Dr. Tatjana Kolevska, medical director for the Kaiser Permanente National Cancer Excellence Program, emphasised the importance of this inquiry.

Studies are being conducted to check if less surgery, chemotherapy or radiation can help patients with ovarian and oesophagal cancers and Hodgkin lymphoma live longer and feel better.

Also Read: DCGI orders withdrawal of Olaparib for select cancer patients over safety concerns

French researchers have discovered that, during surgery for advanced ovarian cancer, it is safe to leave healthy-looking lymph glands untouched. Their study looked at 379 patients, with half having their lymph nodes removed and the other half keeping them, added NY Post.

The research, funded by the National Institute of Cancer in France, found that the longevity of the patients had not been affected even after nine years. Patients had fewer complications after less extreme surgery. They did not require blood transfusions either.

Also Read: GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk

A German study found that 57% of the patients undergoing chemotherapy and surgery were still alive. However, 51% of those who had radiation along with chemo and surgery were alive.

For a type of blood cancer called advanced Hodgkin lymphoma, people with more intense treatment were found less likely to keep their disease in check.

Experts speak

Dr. Kolevska, not involved in the new research that has sparked the discussion, believes it is a question "that should be asked over and over again".

Also Read: Italian doctors, who tended to Pope Francis, flew to London to perform abdominal surgery on Kate Middleton

Dr. William G. Nelson from Johns Hopkins School of Medicine says that cancer treatment, with fewer short-term and long-term complications, is not only improving in effectiveness but also becoming easier to tolerate, the publication added. Dr. Nelson was not involved in the study either.

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:3 Jun 2024, 12:33 PM IST
Business NewsScienceHealthCancer treatment: New research finds ‘less’ is more effective for patients, produce fewer side-effects

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Tata Steel share price

    158.50
    02:44 PM | 14 OCT 2024
    -2.2 (-1.37%)

    Bandhan Bank share price

    200.10
    02:44 PM | 14 OCT 2024
    -10.9 (-5.17%)

    Wipro share price

    550.45
    02:44 PM | 14 OCT 2024
    21.5 (4.06%)

    Indian Oil Corporation share price

    164.95
    02:44 PM | 14 OCT 2024
    1.75 (1.07%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Tech Mahindra share price

    1,687.40
    02:32 PM | 14 OCT 2024
    41.65 (2.53%)

    National Aluminium Company share price

    226.40
    02:32 PM | 14 OCT 2024
    3.7 (1.66%)

    Divis Laboratories share price

    6,210.80
    02:32 PM | 14 OCT 2024
    69.65 (1.13%)

    HCL Technologies share price

    1,859.05
    02:32 PM | 14 OCT 2024
    19.5 (1.06%)
    More from 52 Week High

    Avenue Supermarts share price

    4,190.00
    02:32 PM | 14 OCT 2024
    -382.35 (-8.36%)

    Tata Chemicals share price

    1,106.05
    02:32 PM | 14 OCT 2024
    -78.2 (-6.6%)

    Sapphire Foods India share price

    352.50
    02:29 PM | 14 OCT 2024
    -18.6 (-5.01%)

    Bandhan Bank share price

    200.65
    02:32 PM | 14 OCT 2024
    -10.35 (-4.91%)
    More from Top Losers

    Aptus Value Housing Finance India share price

    394.30
    02:32 PM | 14 OCT 2024
    33.3 (9.22%)

    Finolex Industries share price

    315.65
    02:32 PM | 14 OCT 2024
    16.5 (5.52%)

    Raymond share price

    1,674.70
    02:32 PM | 14 OCT 2024
    71.8 (4.48%)

    Oberoi Realty share price

    1,996.05
    02:32 PM | 14 OCT 2024
    76.75 (4%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      77,675.00-10.00
      Chennai
      77,681.00-10.00
      Delhi
      77,833.00-10.00
      Kolkata
      77,685.00-10.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.86/L0.00
      Chennai
      100.75/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.72/L0.00

      Popular in Science

        HomeMarketsPremiumInstant LoanMint Shorts